In March, a COVID-19 vaccine was tested on 45 healthy adults in Phase 1 tests administered by the National Institutes of Health and Moderna Inc. On Tuesday evening, it was reported that all the participants in the study reflected an immune system boost response, enabling the entities testing the vaccine to start testing it on 30,000 participants starting on July 27, which would make it the largest study in the world.
The results were taken from the younger subjects in the study; results from older adults are currently being analyzed.
.png)
.png)
